Outset Medical, INC Form 4 insider transactions
NASDAQ
John L. Brottem, General Counsel of Outset Medical, Inc., sold shares to cover tax withholding obligations related to vesting RSUs and acquired shares through the Employee Stock Purchase Plan.
NASDAQ
Outset Medical's CEO, Leslie Trigg, sold shares to cover tax withholding obligations related to the vesting of restricted stock units.
NASDAQ
Jean-Olivier Racine, Chief Technology Officer of Outset Medical, sold 8,306 shares of common stock to cover tax withholding obligations related to vesting RSUs.
NASDAQ
SVP of Operations and R&D at Outset Medical, Marc Nash, sold shares to cover tax withholding obligations related to vesting RSUs.
NASDAQ
Director Brent D. Lang received 108,024 Restricted Stock Units (RSUs) from Outset Medical, Inc. on March 12, 2024, which vest quarterly over three years.
NASDAQ
Nabeel Ahmed, CFO of Outset Medical, reports the acquisition of 1,584 shares through the Employee Stock Purchase Plan and the sale of 1,584 shares under a 10b5-1 trading plan.